Martin Brenner - 09 May 2024 Form 4 Insider Report for iBio, Inc. (IBIO)

Role
Chief Executive Officer and Chief Scientific Officer
Signature
/s/ Martin Brenner
Issuer symbol
IBIO
Transactions as of
09 May 2024
Net transactions value
$0
Form type
4
Filing time
13 May 2024, 16:32:43 UTC
Previous filing
03 Nov 2023
Next filing
13 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IBIO Stock Option (right to buy) Award $0 +147,300 $0.000000 147,300 09 May 2024 Common Stock 147,300 $1.88 Direct F1
transaction IBIO Stock Option (right to buy) Award $0 +110,000 $0.000000 110,000 09 May 2024 Common Stock 110,000 $1.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest as follows: 25% of the shares of common stock underlying the options granted will vest on the one-year anniversary of the grant date and after the one-year anniversary of the grant date, 6.25% of the shares of common stock underlying the options granted will vest for each additional three months of employment, provided that the reporting person remains employed by iBio, Inc.
F2 These options vest in equal amounts on a quarterly basis over a 36-month period commencing on the date of grant.

Remarks:

Chief Executive Officer and Chief Scientific Officer